Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1547PDF: 878HTML: 980figures: 178table 1: 181table2: 180table3: 181 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4794PDF: 1785HTML: 2705Untitled: 215 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3912Suppl. Files: 1110PDF: 1065Html: 175 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3268PDF: 1236HTML: 8105 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
840PDF: 486HTML: 1303 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
970PDF: 533HTML: 722 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3684PDF: 1236HTML: 3889Untitled: 211Untitled: 258 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3754PDF: 1482HTML: 485Figures . Eliassian: 222 -
IMMUNOLOGY OF TUBERCULOSIS
5279PDF: 2002HTML: 7319Untitled: 195 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10589PDF: 6350HTML: 21785 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
938PDF: 572HTML: 2192Cover Letter: 190 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3294PDF: 1342HTML: 2625 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1938PDF: 1163HTML: 266 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1385PDF: 816HTML: 3123 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4098PDF: 1585HTML: 948 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1165PDF: 602HTML: 6798 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1376PDF: 1306HTML: 99 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3311PDF: 1315HTML: 6191 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3029PDF: 1024HTML: 3076 -
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1296PDF: 1008HTML: 122 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6940PDF: 3914HTML: 24881







